
Cell Therapy Biomanufacturing: Global Markets
Description
Cell Therapy Biomanufacturing: Global Markets
Report Scope:
This report discusses the key trends shaping the global cell therapy biomanufacturing market, exploring factors that drive or hinder growth while providing valuable insights for stakeholders and potential newcomers. It examines R&D investment, heightened competition, and emerging technologies steering market dynamics. Moreover, the report assesses how advancements, product launches, and governmental initiatives impact future market trajectories. It also scrutinizes corporate actions like mergers, acquisitions, and partnerships. Additionally, the report evaluates the efficacy of various strategies in light of evolving technologies, intensifying competition, and shifting consumer demands.
Report Includes:
17 data tables and 25 additional tables
Analysis of the global markets for cell therapy biomanufacturing
Analyses of global market trends, with market revenue data from 2022, estimates for 2023, forecasts for 2024 and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with a market share analysis by product type, application, end user and region
Facts and figures pertaining to the market dynamics, technological advances, product launches, regulatory scenarios, and the expected impact of macroeconomic factors
An analysis of patents and emerging technologies
Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
An analysis of the industry structure, including companies’ market shares, merger and acquisition activity, and venture funding
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Bristol-Myers Squibb Co., Lonza, Merck KGaA, andBioSenic SA
Companies Mentioned
BIOSENIC
BRISTOL-MYERS SQUIBB CO.
DANAHER CORP.
IOVANCE BIOTHERAPEUTICS INC.
LISATA THERAPEUTICS
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
Table of Contents
112 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Overview
- Cell Therapy
- Stem Cell Transplantation
- Stem Cell Biomanufacturing
- Stem Cell Classification Based on Source
- Stem Cell Classification Based on Ability to Differentiate
- Uses of Stem Cells
- Application of Stem Cells
- Mechanism of Cell Therapy
- Delivery Method of Cell-Based Therapy
- Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Rising Prevalence of Chronic and Degenerative Diseases
- Growing Investment in R&D
- Technological Advancements in Bioprocessing
- Expansion of Cell Therapy Manufacturing Infrastructure
- Market Restraints
- Complexity and Cost of Manufacturing
- Supply Chain Issues
- Product Stability and Shelf Life
- Market Opportunities
- Emerging Therapeutic Applications
- Patient-Centric Healthcare Models
- Chapter 4 Regulatory Structure
- Regulatory Authorities
- Regulatory Pathways
- Quality Assurance
- Manufacturing Standards
- Global Harmonization Efforts
- Chapter 5 Emerging Technologies and Developments
- Newest Technologies/Key Developments
- Advanced Cell Culture Systems
- Genome Editing Technologies
- Bioprocessing Innovation
- Cell Sorting and Purification
- Automation and Robotics
- Data Analytics and Machine Learning
- Tissue Engineering and Organoid Technologies
- Point-of-Care Manufacturing
- Chapter 6 Market Segmentation Analysis
- Key Market Trends
- Cell Therapy Biomanufacturing: Global Markets
- Segmentation Breakdown
- Market Analysis, by Product Type
- Type of Therapy
- Source of Cells
- Market Analysis, by Application
- Skeletal Muscle Repair
- Bone Repair
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Other Diseases
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 7 Competitive Intelligence
- Global Company Ranking
- Strategic Analysis
- M&A and Venture Funding
- Chapter 8 Sustainability in Cell Therapy Biomanufacturing: An ESG Perspective
- Environmental Impact
- Supply Chain Sustainability
- Social Responsibility
- Corporate Governance
- Product Lifecycle Management
- Energy and Water
- Recycling
- Process Design and Materials
- Recycling Single-Use Plastics
- Work Environment
- Chapter 9 Appendix
- Methodology
- Sources
- Acronyms
- Company Profiles
- BIOSENIC
- BRISTOL-MYERS SQUIBB CO.
- DANAHER CORP.
- IOVANCE BIOTHERAPEUTICS INC.
- LISATA THERAPEUTICS
- LONZA
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.